Skip to main content
. 2018 Jul 31;91(1091):20170563. doi: 10.1259/bjr.20170563

Table 2.

Patient characteristics

N (%)
Age (year, range) 70.3 (50–85)
Male/female 14/6 (70/30%)
Location
  Head 17 (85%)
  Body 2 (10%)
  Body/tail 1 (5%)
Performance score
  0 7 (35%)
  1 9 (45%)
  2 3 (15%)
  Missing 1 (5%)
 Classification
  Locally advanced 18 (90%)
  Medically inoperable/ refused surgery 2 (10%)
Chemotherapy (after SBRT)
  FOLFIRINOX 2 (10%)
  Gemcitabine/nab-paclitaxel 2 (10%)
  None 16 (80%)

SBRT, stereotactic body radiation therapy.